Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

LCMV GP (61-80)

🥰Excellent
Catalog No. T39863Cas No. 232598-19-5
Alias LCMVGP (61-80)

LCMV GP (61-80) is a 61-80 amino acid sequence peptide fragment derived from the lymphocytic choroid plexus meningitis virus (LCMV) glycoprotein (GP), which is a specific antigenic determinant that induces CD4+ T cell responses.

LCMV GP (61-80)

LCMV GP (61-80)

🥰Excellent
Catalog No. T39863Alias LCMVGP (61-80)Cas No. 232598-19-5
LCMV GP (61-80) is a 61-80 amino acid sequence peptide fragment derived from the lymphocytic choroid plexus meningitis virus (LCMV) glycoprotein (GP), which is a specific antigenic determinant that induces CD4+ T cell responses.
Pack SizePriceAvailabilityQuantity
1 mg$98 In Stock
5 mg$277 In Stock
10 mg$433 In Stock
25 mg$689 In Stock
50 mg$976 In Stock
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
LCMV GP (61-80) is a 61-80 amino acid sequence peptide fragment derived from the lymphocytic choroid plexus meningitis virus (LCMV) glycoprotein (GP), which is a specific antigenic determinant that induces CD4+ T cell responses.
In vitro
Splenocytes from day 8 LCMV-infected mice were stimulated with LCMV GP (61-80) at 37 °C for 4 h. Intracellular cytokine staining showed that the peptide effectively induced IFN-γ production, demonstrating CD4⁺ T cell activation[1].
In vivo
LCMV GP (61-80) acts as an immunodominant CD4⁺ T cell epitope in LCMV Clone 13-infected mice. On day 8 post-infection, the frequency of GP61-80-specific CD4⁺ T cells increased significantly, indicating strong in vivo immunogenicity[1].
AliasLCMVGP (61-80)
Chemical Properties
Molecular Weight2290.57
FormulaC108H160N24O31
Cas No.232598-19-5
SmilesC(N[C@H](C(N[C@H](C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@H](C(NCC(N[C@H](C(N[C@@H](CC2=CC=C(O)C=C2)C(N[C@H](C(N[C@@H](CC3=CC=CC=C3)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC4=CC=CC=C4)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)CCC(O)=O)=O)[C@H](C)C)=O)CO)=O)CCCCN)=O)=O)CCC(N)=O)=O)=O)C(C)C)=O)=O)CCCCN)=O)=O)[C@H](CC)C)=O)CC(O)=O)(=O)[C@H]5N(C(CNC([C@@H](NC([C@@H](NC(CN)=O)CC(C)C)=O)CCCCN)=O)=O)CCC5
Storage & Solubility Information
Storagekeep away from moisture,keep away from direct sunlight | store at -20°C | Shipping with blue ice./Shipping at ambient temperature.
Solubility Information
H2O: < 0.1 mg/mL (insoluble), Sonication is recommended.

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy LCMV GP (61-80) | purchase LCMV GP (61-80) | LCMV GP (61-80) cost | order LCMV GP (61-80) | LCMV GP (61-80) chemical structure | LCMV GP (61-80) in vivo | LCMV GP (61-80) in vitro | LCMV GP (61-80) formula | LCMV GP (61-80) molecular weight